Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Targeted testing and the diagnosis of latent tuberculosis infection and tuberculosis disease
Filetype[PDF-5.06 MB]


This document cannot be previewed automatically as it exceeds 5 MB
Please click the thumbnail image to view the document.
Targeted testing and the diagnosis of latent tuberculosis infection and tuberculosis disease
Details:
  • Description:
    Course #WB2556

    In this module, you will learn about targeted testing and the diagnosis of latent tuberculosis infection (LTBI) and tuberculosis (TB) disease. Targeted testing is a TB control strategy that is used to identify people who have LTBI, are at high risk for developing TB disease, and would benefit from treatment. LTBI is diagnosed with an interferon-gamma release assay (IGRA) or the Mantoux tuberculin skin test (TST).

    It is important to medically evaluate people who have symptoms of TB disease; if they are found to have TB disease, they need treatment to be cured and to help stop the transmission of TB to others. For this reason, the diagnosis of TB disease is crucial to controlling the spread of TB in homes and communities. In most cases, TB disease is diagnosed with certain laboratory tests. For patients who may have pulmonary TB disease, a chest x-ray is also useful for diagnosis

    CS302141-E

    Module3.pdf

  • Content Notes:
    Background -- Objectives -- New Terms -- Targeted Testing -- Diagnosis of LBTI -- Diagnosis of TB Disease -- TB Genotyping -- Additional Resources -- Answers to Study Questions -- Case Study Answers.
  • Main Document Checksum:
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like: